Abstract
Angiotensinogen gene (AGT) M235T polymorphism is associated with an increased risk of hypertension. It is unknown whether this mutation also leads to an increased risk of development of high blood pressure (BP) in pregnancy. The aim of this study was to investigate the association of this polymorphism with elevated blood pressure during pregnancy in a population of healthy Dutch women. We studied a randomly selected sample of 1,736 middle-aged women who participated in a prospective cohort study of 17,357 Dutch women. After excluding those who had never been pregnant or those with missing data, 429 women with and 921 women without a history of elevated BP during pregnancy remained for further analyses. History of hypertension in pregnancy was assessed using a questionnaire, and confirmed cases varied in severity from mild blood pressure elevation to pre-eclampsia. Individuals with the TT genotype were more likely to have had a history of elevated BP during pregnancy than those with the MM genotype (odds ratio [OR]=1.43; 95% confidence interval [CI], 1.02–2.01; p=0.04). In heterozygote individuals (MT) an increased risk was found, which did not reach statistical significance (OR=1.24; 95% CI, 0.96–1.60; p=0.11). Under both dominant and additive genetic models, the M235T polymorphism was associated with a history of elevated blood pressure during pregnancy, with ORs of 1.29 (95% CI, 1.01–1.64; p=0.04) and 1.20 (95% CI, 1.02– 1.42; p=0.03), respectively. The findings of this study among Caucasian Dutch women, aged 49 to 70 years, demonstrated that the presence of the T allele of the M235T polymorphism in the AGT is associated with self-reported hypertensive disorders in pregnancy.
Similar content being viewed by others
Article PDF
References
Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169–180.
Paillard F, Chansel D, Brand E, et al: Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 1999; 34: 423–429.
Tamaki S, Nakamura Y, Tabara Y, et al: Combined analysis of polymorphisms in angiotensinogen and adducin genes and their effects on hypertension in a Japanese sample: the Shigaraki Study. Hypertens Res 2005; 28: 645–650.
Kato N : Genetic analysis in human hypertension. Hypertens Res 2002; 25: 319–327.
Staessen JA, Kuznetsova T, Wang JG, Emelianov D, Vlietinck R, Fagard R : M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens 1999; 17: 9–17.
Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1–S22.
Ohkuchi A, Iwasaki R, Suzuki H, et al: Normal and highnormal blood pressures, but not body mass index, are risk factors for the subsequent occurrence of both preeclampsia and gestational hypertension: a retrospective cohort study. Hypertens Res 2006; 29: 161–167.
Roberts JM, Lain KY : Recent Insights into the pathogenesis of pre-eclampsia. Placenta 2002; 23: 359–372.
Ohkuchi A, Hirashima C, Matsubara S, et al: Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia. Hypertens Res 2007; 30: 151–159.
Ward K, Hata A, Jeunemaitre X, et al: A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993; 4: 59–61.
Bouba I, Makrydimas G, Kalaitzidis R, Lolis DE, Siamopoulos KC, Georgiou I : Interaction between the polymorphisms of the renin-angiotensin system in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2003; 110: 8–11.
Kobashi G, Hata A, Shido K, et al: Association of a variant of the angiotensinogen gene with pure type of hypertension in pregnancy in the Japanese: implication of a racial difference and significance of an age factor. Am J Med Genet 1999; 86: 232–236.
Morgan L, Crawshaw S, Baker PN, Broughton Pipkin F, Kalsheker N : Maternal and fetal angiotensinogen gene allele sharing in pre-eclampsia. Br J Obstet Gynaecol 1999; 106: 244–251.
Choi H, Kang JY, Yoon HS, et al: Association of angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia. J Korean Med Sci 2004; 19: 253–257.
Wang L, Feng Y, Zhang Y, et al: Prolylcarboxypeptidase gene, chronic hypertension, and risk of preeclampsia. Am J Obstet Gynecol 2006; 195: 162–171.
Bashford MT, Hefler LA, Vertrees TW, Roa BB, Gregg AR : Angiotensinogen and endothelial nitric oxide synthase gene polymorphisms among Hispanic patients with preeclampsia. Am J Obstet Gynecol 2001; 184: 1345–1350.
Onland-Moret NC, van der A DL, van der Schouw YT, et al: Analysis of case-cohort data: a comparison of different methods. J Clin Epidemiol 2007; 60: 350–355.
Cheng S, Grow MA, Pallaud C, et al: A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 1999; 9: 936–949.
Smith GD, Ebrahim S : Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol 2004; 33: 30–42.
van den Born BJ, van Montfrans GA, Uitterlinden AG, Zwinderman AH, Koopmans RP : The M235T polymorphism in the angiotensinogen gene is associated with the risk of malignant hypertension in white patients. J Hypertens 2007; 25: 2227–2233.
van Rijn MJ, Bos MJ, Isaacs A, et al: Polymorphisms of the renin-angiotensin system are associated with blood pressure, atherosclerosis and cerebral white matter pathology. J Neurol Neurosurg Psychiatry 2007; 78: 1083–1087.
Hillermann R, Carelse K, Gebhardt GS : The Glu298Asp variant of the endothelial nitric oxide synthase gene is associated with an increased risk for abruptio placentae in preeclampsia. J Hum Genet 2005; 50: 415–419.
Colhoun HM, McKeigue PM, Davey Smith G : Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361: 865–872.
Lizanecz E, Pasztor ET, Mohacsi A, Papp Z, Edes I, Toth A : Mistyping of angiotensinogen M235T alleles. Hypertens Res 2006; 29: 197–201.
Barton JR, O'brien JM, Bergauer NK, Jacques DL, Sibai BM : Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol 2001; 184: 979–983.
Morgan T, Craven C, Lalouel JM, Ward K : Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua. Am J Obstet Gynecol 1999; 180: 95–102.
Sibai BM, Ewell M, Levine RJ, et al: Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1997; 177: 1003–1010.
Sikkema JM dVH, Huisjes AJ, van Wijk NG, Visser GH, Franx A, Bruinse HW : Insulin resistance in women with a history of early and late onset pre-eclampsia. J Soc Gynecol Investig 2001; 8: 580.
Manten GTR SJ, Voorbij HAM, Visser GHA, Bruinse HW, Franx A : Lipoprotein (a) and other risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction. Hypertens Pregnancy 2004; 23: ( Suppl 1) S51.
Haukkamaa L, Salminen M, Laivuori H, Leinonen H, Hiilesmaa V, Kaaja R : Risk for subsequent coronary artery disease after preeclampsia. Am J Cardiol 2004; 93: 805–808.
Irgens HU, Reisaeter L, Irgens LM, Lie RT : Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001; 323: 1213–1217.
Smith GC, Pell JP, Walsh D : Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001; 357: 2002–2006.
Barden AE, Beilin LJ, Ritchie J, Walters BN, Michael C : Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia? J Hypertens 1999; 17: 1307–1315.
Sattar N, Greer IA : Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002; 325: 157–160.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zafarmand, M., Franx, A., Sabour, S. et al. The M235T Variant of the Angiotensinogen Gene Is Related to Development of Self-Reported Hypertension during Pregnancy: The Prospect-EPIC Cohort Study. Hypertens Res 31, 1299–1305 (2008). https://doi.org/10.1291/hypres.31.1299
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.1299